Head and Neck Langerhans Cell Histiocytosis in Children

Langerhans Cell Histiocytosis (LCH) is a sporadic myeloid neoplasm with proliferation of dendritic cells.1 In the United States, LCH has an estimated annual incidence of approximately 1 per million children.2 Controversy exists regarding management of LCH in head and neck: debridement, chemotherapy, or both. Few reports describe LCH in the OMS literature. The purpose of this study was to present experience with LCH of head and neck in children.This was a retrospective review of children with LCH at Children's Healthcare of Atlanta from 2009 to 2020.

Source: Journal of Oral and Maxillofacial Surgery - October 1, 2021 Category: ENT & OMF Authors: J.Y. Xu, J. Gilbert, K. Sutton, S.L. Goudy, S. Abramowicz Source Type: research